BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vonasek B, Ness T, Takwoingi Y, Kay AW, van Wyk SS, Ouellette L, Marais BJ, Steingart KR, Mandalakas AM. Screening tests for active pulmonary tuberculosis in children. Cochrane Database Syst Rev 2021;6:CD013693. [PMID: 34180536 DOI: 10.1002/14651858.CD013693.pub2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Mckenna L, Sari AH, Mane S, Scardigli A, Brigden G, Rouzier V, Becerra MC, Hesseling AC, Amanullah F. Pediatric Tuberculosis Research and Development: Progress, Priorities and Funding Opportunities. Pathogens 2022;11:128. [DOI: 10.3390/pathogens11020128] [Reference Citation Analysis]
2 Vonasek B, Ness T, Takwoingi Y, Kay AW, van Wyk SS, Ouellette L, Marais BJ, Steingart KR, Mandalakas AM. Screening tests for active pulmonary tuberculosis in children. Cochrane Database Syst Rev 2021;6:CD013693. [PMID: 34180536 DOI: 10.1002/14651858.CD013693.pub2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Van't Hoog A, Viney K, Biermann O, Yang B, Leeflang MM, Langendam MW. Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status. Cochrane Database Syst Rev 2022;3:CD010890. [PMID: 35320584 DOI: 10.1002/14651858.CD010890.pub2] [Reference Citation Analysis]
4 Kohli M, Schiller I, Dendukuri N, Yao M, Dheda K, Denkinger CM, Schumacher SG, Steingart KR. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2021;1:CD012768. [PMID: 33448348 DOI: 10.1002/14651858.CD012768.pub3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]